18 results on '"Pavlakis, Nick"'
Search Results
2. Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta‐analysis
3. Clinical and molecular profile of young adults with early‐onset colorectal cancer: Experience from four Australian tertiary centers
4. Lung cancer treatment patterns and factors relating to systemic therapy use in Australia
5. Epidermal growth factor receptor-tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: A meta-analysis
6. National Working Group Meeting on ALK diagnostics in lung cancer
7. Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series
8. Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study
9. Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigation
10. Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia
11. The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose ( 18 F) positron‐emission tomography positive intermediate grade pancreatic neuroendocrine tumors
12. The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia
13. Cardiac toxicity from sunitinib: Do we need to be more vigilant?
14. Phase III trials of neo-adjuvant chemotherapy in Stage IIIA non-small cell lung cancer – does size matter?
15. Sunitinib malate in the treatment of renal cell carcinoma and gastrointestinal stromal tumor: Recommendations for patient management
16. Pattern of care and survival of anaplastic lymphoma kinase rearranged non-small cell lung cancer (ALK + NSCLC) in an Australian Metropolitan Tertiary Referral Centre: A retrospective cohort analysis
17. Patient-reported experience of the impact and burden of neuroendocrine tumors: Oceania patient results from a large global survey
18. Real-world experience of the feasibility and tolerability of the 2/1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.